Jakubowski A - Search Results

1

Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation.

Jakubowski A, Rath C, Harocopos A, Wright M, Welch A, Kattan J, Navos Behrends C, Lopez-Castro T, Fox AD. Jakubowski A, et al. Harm Reduct J. 2022 Jul 10;19(1):75. doi: 10.1186/s12954-022-00654-0. Harm Reduct J. 2022. PMID: 35818071 Free PMC article.

2

Defining Low-threshold Buprenorphine Treatment.

Jakubowski A, Fox A. Jakubowski A, et al. J Addict Med. 2020 Mar/Apr;14(2):95-98. doi: 10.1097/ADM.0000000000000555. J Addict Med. 2020. PMID: 31567596 Free PMC article.

3

Letter in Reply.

Jakubowski A, Fox A. Jakubowski A, et al. J Addict Med. 2021 Jan-Feb 01;15(1):88-89. doi: 10.1097/ADM.0000000000000692. J Addict Med. 2021. PMID: 32657956 No abstract available.

4

Same-day vs. delayed buprenorphine prescribing and patient retention in an office-based buprenorphine treatment program.

Jakubowski A, Lu T, DiRenno F, Jadow B, Giovanniello A, Nahvi S, Cunningham C, Fox A. Jakubowski A, et al. J Subst Abuse Treat. 2020 Dec;119:108140. doi: 10.1016/j.jsat.2020.108140. Epub 2020 Sep 22. J Subst Abuse Treat. 2020. PMID: 33138925 Free PMC article.

5

"The Doctor Says You Cannot Have [Buprenorphine]" Autonomy and Use of Prescribed or Non-Prescribed Buprenorphine.

Hayes BT, Jakubowski A, Fitzsimmons C, Garcia B, Ramirez F, Fox AD. Hayes BT, et al. Among authors: jakubowski a. Subst Use Misuse. 2021;56(8):1137-1143. doi: 10.1080/10826084.2021.1908360. Epub 2021 May 3. Subst Use Misuse. 2021. PMID: 33939937 Free PMC article.

6

Interest in long-acting injectable buprenorphine among syringe services program participants.

Epstein H, Perez-Correa A, Beltre J, Fitzsimmons C, Marcus P, Ramirez F, Stern LS, Norton BL, Fox AD, Jakubowski A. Epstein H, et al. Among authors: jakubowski a. J Opioid Manag. 2021;17(7):59-67. doi: 10.5055/jom.2021.0643. J Opioid Manag. 2021. PMID: 34520027

7

Participants of a mail delivery syringe services program are underserved by other safe sources for sterile injection supplies.

Hayes BT, Favaro J, Coello D, Behrends CN, Jakubowski A, Fox AD. Hayes BT, et al. Among authors: jakubowski a. Int J Drug Policy. 2022 Jan;99:103474. doi: 10.1016/j.drugpo.2021.103474. Epub 2021 Oct 5. Int J Drug Policy. 2022. PMID: 34619446 Free PMC article.

8

Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes.

Jakubowski A, Norton BL, Hayes BT, Gibson BE, Fitzsimmons C, Stern LS, Ramirez F, Guzman M, Spratt S, Marcus P, Fox AD. Jakubowski A, et al. J Addict Med. 2022 Jul-Aug 01;16(4):447-453. doi: 10.1097/ADM.0000000000000934. Epub 2021 Nov 12. J Addict Med. 2022. PMID: 34775441 Free PMC article.

9

Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: Design and rationale.

Perez-Correa A, Abbas B, Riback L, Ghiroli M, Norton B, Murphy S, Jakubowski A, Hayes BT, Cunningham CO, Fox AD. Perez-Correa A, et al. Among authors: jakubowski a. Contemp Clin Trials. 2022 Mar;114:106674. doi: 10.1016/j.cct.2021.106674. Epub 2022 Jan 3. Contemp Clin Trials. 2022. PMID: 34990854 Free PMC article. Clinical Trial.

10

Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation.

Jakubowski A, Singh-Tan S, Torres-Lockhart K, Nahvi S, Stein M, Fox AD, Lu T. Jakubowski A, et al. Addict Sci Clin Pract. 2023 May 18;18(1):31. doi: 10.1186/s13722-023-00386-x. Addict Sci Clin Pract. 2023. PMID: 37198707 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

398 results

Search Page